Prediction Case File
YouTubeTracking Live

SoFi Stock Is Ready to Explode (Here's Why)

1 extracted signal · 0 resolved · 1 still active

The Patient Investor profile imageThe Patient InvestorIndependent analyst profile
Source published
03 Aug 2026, 18:10 UTC
Recorded by Tahlil Plus
03 Aug 2026, 19:25 UTC
Video preview for SoFi Stock Is Ready to Explode (Here's Why)
Source overview

AI-generated source summary

The analysis focuses on SOFI stock, presenting a bullish outlook based on its valuation and growth prospects. The current share price is $16.31. The projected target price is $39.31, implying a potential upside of 141%. This valuation is derived from a forward P/E ratio of 20, which the analyst considers low given the company's growth potential. The analyst anticipates a target price of $50 for SOFI if it trades at a 25x forward P/E ratio. The company is projected to achieve a 30% CAGR in net revenue and a 42% CAGR in earnings per share between 2025 and 2028. The tangible book value per share is growing at 64.17% year-over-year, reaching $6.70. The stock is currently trading at a tangible book value of $20, which is considered a crucial level. The analyst suggests that if SOFI trades at a 2x tangible book value, its price could reach $40, with a 20.52% implied upside from the current share price. The analyst also notes that SOFI's business model is not a traditional bank, and its ability to generate free cash flow and its strong balance sheet are key supporting factors. The analyst indicates that the stock is undervalued, especially given its long-term growth potential and the possibility of future acquisitions.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Tracking Live
Signals
1
Extracted from this source
Open
1
Still being tracked
Successful
0
Resolved successfully
Failed
0
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
0 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Source processing completed

    Source analysis and structured extraction completed.

  5. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  6. Live evaluation in progress

    1 signal remains active.

Analyst snapshot

The Patient Investor

Platform-wide history, separate from this source evaluation.

Reliability
47.9
Tracked signals
311
Historical success
34.8%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail